Item 3.03 Material Modification to Rights of Security Holders
As previously disclosed on a Current Report on Form 8-K dated July 26, 2022,
Health Sciences Acquisitions Corporation 2 (the "Company") held an extraordinary
general meeting of its shareholders at which the shareholders approved a special
resolution (the "Extension Proposal") to amend the Company's amended and
restated memorandum and articles of association to: (a) extend from August 6,
2022 (the "Original Termination Date") to November 6, 2022 (the "Extended
Date"), the date by which, if the Company has not consummated a merger,
amalgamation, share exchange, asset acquisition, share purchase, reorganisation
or similar business combination involving one or more businesses or entities,
the Company must: (i) cease all operations except for the purpose of winding up;
(ii) as promptly as reasonably possible but not more than ten business days
thereafter, redeem the shares sold in the Company's initial public offering; and
(iii) as promptly as reasonably possible following such redemption, liquidate
and dissolve, subject in each case to its obligations under Cayman Islands law
to provide for claims of creditors and in all cases subject to the other
requirements of applicable law, and (b) allow the Company, without another
shareholder vote, to elect to extend the date to consummate a business
combination on a monthly basis for up to three times by an additional one month
each time after the Extended Date, upon five days' advance notice prior to the
applicable deadlines, until February 6, 2023 or a total of up to six months
after the Original Termination Date, unless the closing of the Company's initial
business combination shall have occurred.
On November 15, 2022, the Directors of the Company elected to extend the
deadline until January 6, 2023.
1© Edgar Online, source Glimpses
HEAH SCIE 
